Second Xiangya Hospital of Central South University
Changsha, China
Location status: Recruiting
NCT Number: NCT07129148
The value of intelligent lifestyle intervention for T2D and its complications has been initially explored, but evidence-based support for the effectiveness of related AI risk prediction models and intervention models remains to be confirmed. The primary objective of this study is to verify the effectiveness of an AI model for predicting the risk of T2D complications based on phenotype, laboratory indicators and wearable device indicators, and to explore the effect and applicability of an intelligent lifestyle intervention model combining wearable devices and smartphones in preventing T2D complications.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Changsha, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Routine doctor-patient interaction.
Wearable monitoring + CGM management platform-assisted administration
Mini-program-assisted health management
Wearable monitoring + mini-program integrated management
Time frame: Baseline, 1 year
Between-group differences in HbA1c change (from Central Lab)
Interested in participating?
Request InfoSecond Xiangya Hospital of Central South University
Other
Study on the Applicability of New Technologies for Diabetes Complication Management Based on Mobile Health and Wearable Devices
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01803828
Cardiomyopathies, Cardiovascular Diseases
Rome, Italy
View Trial DetailsNCT07595718
Arthritis, Back Pain
Seoul, Seoul Special City, South Korea
View Trial DetailsNCT07839546
Body Weight, Diabetes Mellitus
Thessaloniki, Greece
View Trial DetailsNCT07245082
Behavior, Body Weight
Taipei, Zhongzheng Dist, Taiwan
View Trial Details